Non-invasive prenatal testing

Non-invasive prenatal testing (NIPT) is a technique that can be used to test a fetus for genetic conditions and variations, such as Down’s syndrome. It involves taking a blood sample from the pregnant woman at around 9 or 10 weeks of pregnancy. NIPT is more accurate than some other screening tests, it carries no risk of miscarriage and, in some circumstances, NIPT can provide earlier results than current screening and diagnostic tests.

This report considers, at this early stage of its use, how NIPT could change the way we view pregnancy, disability and difference, and what the wider consequences of its increasing use might be.

    Previous work

    Contact us

    Nuffield Council on Bioethics
    28 Bedford Square
    London
    WC1B 3JS

    bioethics@nuffieldbioethics.org

    +44 (0)20 7681 9619

    Sign up for e-news

    Community

    Explore by topic